About Jasmina Marjanovic
Form D filings for EvolveImmune Therapeutics Holding Company in 2024 list Jasmina Marjanovic as director.
Jasmina Marjanovic first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jasmina Marjanovic in the role, so the role may have started earlier or lasted longer.
EvolveImmune Therapeutics Holding Company, LLC
Director
2024 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.
Key Colleagues at Startups
The people Jasmina Marjanovic works with at each company, as listed on that company's latest Form D.
EvolveImmune Therapeutics Holding Company, LLC · Form D, Nov 1, 2024

Donmienne Leung
Director
IT
Ian Taylor
Director
DY
Derek Yoon
Director
SB
Stephen Bloch
Co-founder and Chief Executive Officer, director
DP
Denis Patrick
Director